Form D · Pharmaceuticals
Sirion Holdings, Inc.
Tampa, FL · CIK 1355015
Offering snapshot reported Aug 31, 2009 · SEC filing
- Reported sold
- $1M Offering amount: $2M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 27, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2009 | Initial | $1,000,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-95293
Source: Form D, filed Aug 31, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Susan Benton | Executive |
| James Butler | Director |
| Barry Butler | Director, Executive |
| Todd Creech | Executive |
| Kevin Kinsella | Director |
| Anthony Maida | Director |
| Liza Page Nelson | Director |
| Thomas Riedhammer | Director |
| Andrew Schiff | Director |
| Roger Vogel | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9314 East Broadway Avenue
Tampa, FL, 33619
Tampa, FL, 33619